Three details:
- Medtronic said hackers could potentially deliver or block doses of insulin, which poses a danger for the wearer, according to an October news release.
- In 2018, a cybersecurity researcher discovered the vulnerability of its insulin pumps and remote control. The recall has been expanded because Medrontic determined the potential risks outweigh the benefits of its continued use, according to the release.
- Medtronic has not received any reports of injuries caused by the vulnerability, the company said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
